Earlier studies have shown that the expression of ASCL1 declines in patients with SCLC and in SCLC cells following cisplatin treatment, particularly in cases with acquired chemoresistance, in comparison to untreated samples (42). This evidence concerns the gene ASCL1 and small cell lung carcinoma.